Health TrialsbyHealthPanel

The Effect of Paravertebral Block on Recovery After CABG Surgery

ConditionsCoronary Artery Bypass SurgeryParavertebral Block
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorAdiyaman University Research Hospital

About this trial

The study aims to evaluate the analgesic efficacy of paravertebral block, mobilization speed, respiratory functions, and complication rates in patients who have undergone cardiac surgery and are monitored in the intensive care unit during the postoperative period.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Patients aged 18 and older scheduled for elective coronary artery bypass graft surgery with median sternotomy

Disqualifiers

Contraindications to neuroaxial block ( coagulopathy, infection at the injection site, allergy to local anesthetics..)

Emergency surgeries

severe back deformities

Chronic pain

Trial design

Design model

Parallel

Treatments tested in this trial

  • paravertebral block

    Procedure/Surgery

    A single-dose bilateral paravertebral block will be administered under ultrasound guidance before the induction of general anesthesia. The block will be performed at an appropriate thoracic level using 20 mL of 0.25% bupivacaine as the local anesthetic.

Treatment groups

120 Participants
are divided into 2 treatment groups
Group A: Control groupNo intervention 0 interventions
Group B: Block groupExperimental treatment 1 intervention

Trial outcomes

Primary outcomes

1

Quality of Recovery -15 (QoR-15) score

The QoR-15 is a clinically acceptable and feasible patient-centred outcome measure after surgery. The score demonstrated good validity, reliability and responsiveness. The score ranges from 0 to 150. O refers to the worst recovery and 150 refers to best recovery.

Time frame
Postoperative 24th hours

Secondary outcomes

1

Visual Analog scale (VAS) score

The Visual Analog Scale (VAS) score is a pain assessment tool. The score ranges from 0 to 10, with 0 indicating no pain and 10 indicating the worst pain ever experienced

Time frame
Postoperative 2nd, 4th, 6th, 12th and 24th hours
2

Opioid consumption

Total opioid consumption in first postoperative day will be recorded

Time frame
Postoperative 24th hours
3

Extubation time

Time frame from the end of the surgery to extubation will be recorded

Time frame
Time frame from the end of the surgery to extubation

Other outcomes

Locations

This trial has no locations.

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Adiyaman University Research Hospital

Lead sponsor

Source ClinicalTrials.gov

This trial is not recruiting at the moment. You can still explore other options: